Institution:
Albert Einstein College of MedicineResearchers:
Susan Horwitz, PhD, distinguished professor molecular pharmacology and the Rose C. Falkenstein Chair in Cancer Research at Albert Einstein College of Medicine
Impact:
In December 1992, the FDA approved Taxol for the treatment for ovarian cancer. Researchers also tested the effectiveness of Taxol as a treatment for advanced breast cancer. Subsequent clinical trials found that the drug was effective against this disease, and, in 1994, the FDA approved Taxol for use
Timeline:
Research began in 1977.